158 related articles for article (PubMed ID: 1989648)
1. Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.
Krüger KH; Thompson LF; Kaufmann M; Möller P
Br J Cancer; 1991 Jan; 63(1):114-8. PubMed ID: 1989648
[TBL] [Abstract][Full Text] [Related]
2. Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.
Christensen LD; Andersen V; Ryder L
Scand J Immunol; 1996 Jul; 44(1):62-70. PubMed ID: 8693293
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).
Thomson LF; Ruedi JM; Glass A; Moldenhauer G; Moller P; Low MG; Klemens MR; Massaia M; Lucas AH
Tissue Antigens; 1990 Jan; 35(1):9-19. PubMed ID: 2137649
[TBL] [Abstract][Full Text] [Related]
4. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
5. Ecto-enzyme and signaling functions of lymphocyte CD73.
Resta R; Yamashita Y; Thompson LF
Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
[TBL] [Abstract][Full Text] [Related]
6. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
Wang L; Zhou X; Zhou T; Ma D; Chen S; Zhi X; Yin L; Shao Z; Ou Z; Zhou P
J Cancer Res Clin Oncol; 2008 Mar; 134(3):365-72. PubMed ID: 17671792
[TBL] [Abstract][Full Text] [Related]
7. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
Christensen LD
APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
[TBL] [Abstract][Full Text] [Related]
8. CD73 (ecto-5'-nucleotidase) on blood mononuclear cells. Regulation of ecto-5'-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency.
Christensen LD
APMIS Suppl; 1997; 73():1-28. PubMed ID: 9393563
[No Abstract] [Full Text] [Related]
9. CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities.
Bauer FN; Tertel T; Stambouli O; Wang C; Dittrich R; Staubach S; Börger V; Hermann DM; Brandau S; Giebel B
Cytotherapy; 2023 Feb; 25(2):138-147. PubMed ID: 36244910
[TBL] [Abstract][Full Text] [Related]
10. CD73 expression as a potential marker of good prognosis in breast carcinoma.
Supernat A; Markiewicz A; Welnicka-Jaskiewicz M; Seroczynska B; Skokowski J; Sejda A; Szade J; Czapiewski P; Biernat W; Zaczek A
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):103-7. PubMed ID: 22553809
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix.
Zhou P; Zhi X; Zhou T; Chen S; Li X; Wang L; Yin L; Shao Z; Ou Z
Cancer Biol Ther; 2007 Mar; 6(3):426-31. PubMed ID: 17471030
[TBL] [Abstract][Full Text] [Related]
12. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
[TBL] [Abstract][Full Text] [Related]
13. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Turcotte M; Allard D; Mittal D; Bareche Y; Buisseret L; José V; Pommey S; Delisle V; Loi S; Joensuu H; Kellokumpu-Lehtinen PL; Sotiriou C; Smyth MJ; Stagg J
Cancer Res; 2017 Oct; 77(20):5652-5663. PubMed ID: 28855210
[TBL] [Abstract][Full Text] [Related]
14. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
15. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.
Zhi X; Chen S; Zhou P; Shao Z; Wang L; Ou Z; Yin L
Clin Exp Metastasis; 2007; 24(6):439-48. PubMed ID: 17587186
[TBL] [Abstract][Full Text] [Related]
16. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.
Möller P; Mechtersheimer G; Kaufmann M; Moldenhauer G; Momburg F; Mattfeldt T; Otto HF
Virchows Arch A Pathol Anat Histopathol; 1989; 414(2):157-64. PubMed ID: 2464868
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD73 and its ecto-5'-nucleotidase activity are elevated in papillary thyroid carcinomas.
Kondo T; Nakazawa T; Murata SI; Katoh R
Histopathology; 2006 Apr; 48(5):612-4. PubMed ID: 16623792
[No Abstract] [Full Text] [Related]
19. CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer.
Leclerc BG; Charlebois R; Chouinard G; Allard B; Pommey S; Saad F; Stagg J
Clin Cancer Res; 2016 Jan; 22(1):158-66. PubMed ID: 26253870
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.
Airas L; Niemelä J; Salmi M; Puurunen T; Smith DJ; Jalkanen S
J Cell Biol; 1997 Jan; 136(2):421-31. PubMed ID: 9015312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
